Tue, Jul 29, 2014, 6:59 AM EDT - U.S. Markets open in 2 hrs 31 mins

Recent

% | $
Click the to save as a favorite.

Hemispherx Biopharma, Inc. Message Board

  • cynicallacinyc cynicallacinyc May 28, 2009 4:19 PM Flag

    Here Is The Paragraph Summarized By The Bald Headed Champ!!!

    I believe he doesn't know what he has read. He said in his article that the study shows no statistical significance but he only extracted one number of two and "In my Opinion" he was dead wrong. Buy your shares back quick before approval is announced. He provided a link in his text to view the clinical review. You better go there and review it for yourself before you get left behind!

    In the recently completed Phase 3 trial, patients receiving Ampligen for 40 weeks improved exercise treadmill performance 14.8% compared to the placebo group (p = 0.025) and 12.9% by intent to treat analysis (p = 0.052), and this improvement represents twice the minimum considered medically significant (6.5%).

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • This is the letter I wrote to Adam Feurstein also. His point about statistical significance on Intent on Treat Analysis to the point. BUT, he selectively leaves lot of other text from the abstact, I wonder why.

      Hi Adam
      Without making any direct remarks at your opinion, my question is this:

      "In the recently completed Phase 3 trial, patients receiving Ampligen for 40 weeks improved exercise treadmill performance 14.8% compared to the placebo group (p = 0.025) and 12.9% by intent to treat analysis (p = 0.052), and this improvement represents twice the minimum considered medically significant (6.5%). "

      I copied that from the abstract linked in your opinion piece. The peer reviewed study's abstract claims twice the minimum medical significance. yet you are chosing to just harp on statistical significance. Further if you read the the abstract it clearly mentions that "Primary endpoints have been achieved with statistical significance. "

      More on p values:

      http://pharmrep.findpharma.com/pharmrep/article/articleDetail.jsp?id=103687

 
HEB
0.264-0.006(-2.19%)Jul 28 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.